Status:

ENROLLING_BY_INVITATION

PET-MRI in Chronic Traumatic Brain Injury (CTBI)

Lead Sponsor:

Thomas Jefferson University

Conditions:

Chronic Traumatic Brain Injury

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Chronic Traumatic Brain Injury (cTBI) symptoms exist in individuals who experienced previous traumatic brain injuries. There are 80-90 thousand individuals who are clinically diagnosed with cTBI, with...

Detailed Description

The purpose of this project was to create a comprehensive, extensive, longitudinal diagnostic evaluation of cTBI patients. The evaluation uses a battery of neurocognitive tests, laboratory levels of s...

Eligibility Criteria

Inclusion

  • Individuals with a history of TBI and complaints of persistent symptoms including cognitive impairment, emotional disturbances, headache, or other symptoms associated with TBI
  • Age 18-80 years old
  • Patients had no other pre-existing history (i.e. prior to the TBI) of significant medical, neurological, or psychological disorders such as schizophrenia or active substance abuse.
  • Minor, stable health problems that should have no substantial effect on cerebral blood flow will be allowed (i.e. controlled hypertension, medication controlled diabetes)
  • Able to give informed consent and willing to complete the study
  • Patients will be allowed to be taking medications or supplements at the initial intake, but they must be on a stable dose regimen for at least 1 month
  • Women of childbearing potential will confirm a negative pregnancy test NET Substudy: Anxiety and/or distress associated with TBI or TBI symptoms by measurement with Subjective Units of Distress, and biofeedback screening

Exclusion

  • Previous brain surgery.
  • Cognitive impairment with significant impact on activities of daily living and/or a score on the Mini-Mental Status examination (or similar) of 25 or lower
  • Intracranial abnormalities that may complicate interpretation of the brain scans (e.g., stroke, tumor, vascular abnormality affecting the target area).
  • Pregnant or lactating women.
  • Enrollment in active clinical trial/ experimental therapy within the prior 30 days.
  • Any pre-existing medical conditions that may interfere with cerebral function.
  • Subject is unable or unwilling to lie still in the scanner (i.e. due to claustrophobia or weight \> 350 pounds)
  • Subject has metal in their body or other reason that they cannot undergo magnetic resonance imaging.
  • Additional exclusionary criteria for the NAC arm:
  • Patients taking medications that might interact with the NAC involved in this study will be evaluated on a case by case basis by the PI or study physician.
  • Patients that have a history of uncontrolled conditions, e.g.: diabetes, asthma, gastroesophageal reflex disease, or thyroid conditions

Key Trial Info

Start Date :

June 7 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 8 2027

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT03241732

Start Date

June 7 2017

End Date

July 8 2027

Last Update

July 29 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Thomas Jefferson University, Marcus Institute of Integrative Health Centers

Philadelphia, Pennsylvania, United States, 19107

2

Thomas Jefferson University, Marcus Institute of Integrative Health Centers

Villanova, Pennsylvania, United States, 19085